semaglutide stock photo Hims? Hers? It's Novo Nordisk's Market Now Semaglutide Images - Free Download

What we'd expect long-term based on available data: Weight loss continues through at least 104 weeks in most patients Estimated peak loss: 3032% in patients reaching maximum dose and maintaining treatment Maintenance phase: stable weight if treatment continues without dose reduction Weight regain after stopping is near-universal with all GLP-1 medications

By taking control, you can reignite your metabolism and regain muscle mass

Initially developed as a treatment for type 2 diabetes, the drug gained widespread attention after clinical trials showed it reduced baseline body weight by approximately 10%-15%

At Frisco Quick Care, Wegovy is offered as an evidence-based, FDA-approved option for chronic weight management

If you like fizz, try a slowly carbonated drink in small sips away from meals to reduce air swallowing

Safety Considerations and Side Effects of GLP-1 Agonists Whilst GLP-1 receptor agonists are generally well-tolerated, patients and prescribers must be aware of potential adverse effects and important safety considerations